Skip to main content
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SNOA ISIN · US83558L2043 US Manufacturing
Open in API
Filings indexed 951 across all filing types
Latest filing 2016-10-21 Regulatory Filings
Country US United States of America
Listing US SNOA

About Sonoma Pharmaceuticals, Inc.

https://sonomapharma.com/

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.

Recent filings

Filing Released Lang Actions
FORM 8-A 12(B)
Regulatory Filings Classification · 95% confidence The document is a Form 8-A filed with the SEC for registration of certain classes of securities pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934. It describes the terms of a Rights Agreement related to preferred stock purchase rights, including detailed provisions about exercisability, redemption, and other terms. The document is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration. It is not an announcement of a report but the actual registration statement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2016-10-21 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the adoption of a Section 382 rights agreement and related corporate actions such as issuance of preferred stock rights to protect net operating loss carryforwards. It includes detailed terms of the rights agreement, board approval, and filing of related certificates. There are no financial statements or quarterly/yearly financial results presented, nor is this a transcript, proxy, or dividend notice. The document is an announcement of a material definitive agreement and amendments to corporate governance documents, typical of an 8-K filing. This fits best under Regulatory Filings (RNS) as it is a regulatory announcement of a corporate action and not a full report or financial statement. The document length and detail confirm it is not a brief announcement but a full regulatory filing. Therefore, the classification is RNS with high confidence.
2016-10-21 English
FORM 8-K AMENDMENT
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K/A, which is an amendment to a current report filed with the SEC. It specifically reports the submission of matters to a vote of security holders at an annual meeting, including detailed voting results on a proposal related to the 2016 Equity Incentive Plan. The content focuses on the official results of shareholder votes at a general meeting. The document length is 3038 characters, which is relatively short and consistent with a voting results announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2016-09-19 English
FORM 424B3
Capital/Financing Update Classification · 100% confidence The document is a Form 424B3 prospectus supplement filed pursuant to Rule 424(b)(3) related to a public offering of common stock and warrants by Oculus Innovative Sciences, Inc. It details the terms of the offering, underwriting arrangements, use of proceeds, risk factors, and summary financial information. This type of filing is a capital raising document describing financing activities and securities issuance. It is not an annual or quarterly report, earnings release, or management discussion. The presence of underwriting details, offering price, shares issued, and warrants confirms it is a Capital/Financing Update filing.
2016-09-09 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated September 2, 2016, reporting the submission of matters to a vote of security holders at the company's annual meeting. It details the voting results on director elections, executive compensation advisory vote, appointment of the independent auditor, and an equity incentive plan vote. This matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not a full annual report or proxy statement but specifically reports voting outcomes. The length is 4485 characters, which is sufficient for detailed voting results. Therefore, the correct classification is DVA with high confidence.
2016-09-09 English
FORM 4
Director's Dealing
2016-08-30 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.